vimarsana.com
Home
Live Updates
Apraglutide Reduces Parenteral Support Dependency in Patient
Apraglutide Reduces Parenteral Support Dependency in Patient
Apraglutide Reduces Parenteral Support Dependency in Patients with SBS-IF, CIC
Final data from STARS Nutrition were presented at United European Gastroenterology Week 2023, demonstrating a significant reduction in parenteral support.
Related Keywords
Linkedin Tim Vanuytsel ,
Tim Vanuytsel ,
Ironwood Pharmaceuticals Presents Positive Final Data ,
Transplantation Center ,
Ironwood Pharmaceuticals ,
United European Gastroenterology Week ,
Leuven Intestinal Failure ,
Short Bowel Syndrome ,
Intestinal Failure ,
United European Gastroenterology ,
Vectivbio Reports Positive Interim Clinical Data ,
Investigating Apraglutide ,
Intestinal Failure Patients ,
Balance Study ,
Patients With ,
Stars Nutrition ,
Stars ,
Phase 2 ,
Study ,
Trial ,
Apraglutide ,
Parenteral Support ,
Sbs If ,
Colon In Continuity ,
Cic ,
Glp 2 ,
Receptor ,